Omeros Corp (OMER) stock
OMERNasdaqPharmaceutical PreparationsFiscal year ends December 31
$17.49−0.50 (-2.78%)
Close on Nov 13, 2026Market cap $1.27BP/E –Yield –
Omeros gross margin
Gross margin is gross profit as a percentage of revenue.
Omeros's gross margin for the twelve months ending Mar 31, 2021 was 98.7%. For fiscal 2020 it was 98.8%, against 99.2% the year before. The highest annual figure on record is 100.0% in fiscal 2013.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2020 | Dec 31, 2020 | 98.8% | −0.4 |
| FY2019 | Dec 31, 2019 | 99.2% | +0.9 |
| FY2018 | Dec 31, 2018 | 98.3% | −0.1 |
| FY2017 | Dec 31, 2017 | 98.3% | +1.7 |
| FY2016 | Dec 31, 2016 | 96.6% | +4.3 |
| FY2015 | Dec 31, 2015 | 92.3% | −7.7 |
| FY2014 | Dec 31, 2014 | 100.0% | +0.0 |
| FY2013 | Dec 31, 2013 | 100.0% | – |
Quarterly gross margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 97.2% | −1.3 |
| Q1 FY2026 | Mar 31, 2026 | 94.1% | −4.8 |
| Q1 FY2021 | Mar 31, 2021 | 98.8% | −0.1 |
| Q4 FY2020 | Dec 31, 2020 | 99.2% | +0.4 |
| Q3 FY2020 | Sep 30, 2020 | 98.5% | −0.6 |
| Q2 FY2020 | Jun 30, 2020 | 98.9% | −0.9 |
| Q1 FY2020 | Mar 31, 2020 | 98.9% | −0.5 |
| Q4 FY2019 | Dec 31, 2019 | 98.8% | −0.5 |
| Q3 FY2019 | Sep 30, 2019 | 99.1% | −0.1 |
| Q2 FY2019 | Jun 30, 2019 | 99.8% | +6.8 |
| Q1 FY2019 | Mar 31, 2019 | 99.4% | +12.2 |
| Q4 FY2018 | Dec 31, 2018 | 99.3% | +2.7 |
| Q3 FY2018 | Sep 30, 2018 | 99.2% | +0.1 |
| Q2 FY2018 | Jun 30, 2018 | 93.0% | −6.1 |
| Q1 FY2018 | Mar 31, 2018 | 87.2% | −10.6 |
| Q4 FY2017 | Dec 31, 2017 | 96.6% | −0.4 |
| Q3 FY2017 | Sep 30, 2017 | 99.2% | +2.5 |
| Q2 FY2017 | Jun 30, 2017 | 99.1% | +2.4 |
| Q1 FY2017 | Mar 31, 2017 | 97.8% | – |
| Q4 FY2016 | Dec 31, 2016 | 97.1% | – |
| Q3 FY2016 | Sep 30, 2016 | 96.7% | – |
| Q2 FY2016 | Jun 30, 2016 | 96.7% | – |
See a number that looks wrong?